Endocrine Disruption of Androgenic Activity by Perfluoroalkyl Substances: Clinical and Experimental Evidence
Author(s) -
Andrea Di Nisio,
Iva Šabović,
Umberto Valente,
Simone Tescari,
Maria Santa Rocca,
Diego Guidolin,
Stefano Dall’Acqua,
Laura Acquasaliente,
Nicola Pozzi,
Mario Plebani,
Andrea Garolla,
Carlo Foresta
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01855
Subject(s) - endocrine system , testosterone (patch) , hormone , semen quality , physiology , male infertility , infertility , biology , perfluorooctanoic acid , medicine , endocrinology , semen , andrology , pregnancy , genetics , biochemistry
Considerable attention has been paid to perfluoroalkyl compounds (PFCs) because of their worldwide presence in humans, wildlife, and environment. A wide variety of toxicological effects is well supported in animals, including testicular toxicity and male infertility. For these reasons, the understanding of epidemiological associations and of the molecular mechanisms involved in the endocrine-disrupting properties of PFCs on human reproductive health is a major concern.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom